[Federal Register Volume 88, Number 58 (Monday, March 27, 2023)]
[Notices]
[Pages 18141-18142]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06226]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[Document Identifiers CMS-10221 and CMS-10788]


Agency Information Collection Activities: Proposed Collection; 
Comment Request

AGENCY: Centers for Medicare & Medicaid Services, Health and Human 
Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is 
announcing an opportunity for the public to comment on CMS' intention 
to collect information from the public. Under the Paperwork Reduction 
Act of 1995 (the PRA), federal agencies are required to publish notice 
in the Federal Register concerning each proposed collection of 
information (including each proposed extension or reinstatement of an 
existing collection of information) and to allow 60 days for public 
comment on the proposed action. Interested persons are invited to send 
comments regarding our burden estimates or any other aspect of this 
collection of information, including the necessity and utility of the 
proposed information collection for the proper performance of the 
agency's functions, the accuracy of the estimated burden, ways to 
enhance the quality, utility, and clarity of the information to be 
collected, and the use of automated collection techniques or other 
forms of information technology to minimize the information collection 
burden.

DATES: Comments must be received by May 26, 2023.

ADDRESSES: When commenting, please reference the document identifier or 
OMB control number. To be assured consideration, comments and 
recommendations must be submitted in any one of the following ways:
    1. Electronically. You may send your comments electronically to 
http://www.regulations.gov. Follow the instructions for ``Comment or 
Submission'' or ``More Search Options'' to find the information 
collection document(s) that are accepting comments.
    2. By regular mail. You may mail written comments to the following 
address: CMS, Office of Strategic Operations and Regulatory Affairs, 
Division of Regulations Development, Attention: Document Identifier/OMB 
Control Number:__ Room C4-26-05, 7500 Security Boulevard, Baltimore, 
Maryland 21244-1850.
    To obtain copies of a supporting statement and any related forms 
for the proposed collection(s) summarized in this notice, please access 
the CMS PRA website by copying and pasting the following web address 
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.

FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.

SUPPLEMENTARY INFORMATION:

Contents

    This notice sets out a summary of the use and burden associated 
with the following information collections. More detailed information 
can be found in each collection's supporting statement and associated 
materials (see ADDRESSES).

CMS-10221 Independent Diagnostic Testing Facilities (IDTFs) Site 
Investigation Collection
CMS-10788 Prescription Drug and Health Care Spending

    Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain 
approval from the Office of Management and Budget (OMB) for each 
collection of information they conduct or sponsor. The term 
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
1320.3(c) and includes agency requests or requirements that members of 
the public submit reports, keep records, or provide information to a 
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies 
to publish a 60-day notice in the Federal Register concerning each 
proposed collection of information, including each proposed extension 
or reinstatement of an existing collection of information, before 
submitting the collection to OMB for approval. To comply with this 
requirement, CMS is publishing this notice.

Information Collection

    1. Type of Information Collection Request: Extension of currently 
approved collection; Title of Information Collection: Independent 
Diagnostic Testing Facilities (IDTFs) Site Investigation Collection; 
Use: The purpose of the site investigation is to ensure that the IDTF 
is in compliance with the provisions of 42 CFR 410.33, as well as all 
other applicable Federal, State and local laws and regulations. It is 
also used to verify the information the IDTF furnished on its CMS- 855B 
enrollment application. Sections 1814(a), 1815(a), and 1833(e) of the 
Act require the submission of information necessary to determine the 
amounts due

[[Page 18142]]

to a provider or other person. To fulfill this requirement, CMS must 
collect information on any IDTF supplier who submits a claim to 
Medicare or who applies for a Medicare billing number before allowing 
the IDTF to enroll. This information must, minimally, clearly identify 
the provider and its' place of business as required by CFR 424.500 
(Requirements for Establishing and Maintaining Medicare Billing 
Privileges) and provide all necessary documentation to show they are 
qualified to perform the services for which they are billing. The site 
inspection form allows inspectors to verify the information using a 
standardized information collection methodology. Form Number: CMS-10221 
(OMB control number: 0938-1029); Frequency: Occasionally; Affected 
Public Sector: Private Sector (Business or other for-profits and Not-
for-profit institutions); Number of Respondents: 652; Total Annual 
Responses: 652; Total Annual Hours: 1,304. (For policy questions 
regarding this collection contact Angelika Broznowicz at 410-786-8242).
    2. Type of Information Collection Request: Revision of currently 
approved collection; Title of Information Collection: Prescription Drug 
and Health Care Spending; Use: On December 27, 2020, the Consolidated 
Appropriations Act, 2021 (CAA) was signed into law. Section 204 of 
Title II of Division BB of the CAA added parallel provisions at section 
9825 of the Internal Revenue Code (the Code), section 725 of the 
Employee Retirement Income Security Act (ERISA), and section 2799A-10 
of the Public Health Service Act (PHS Act) that require group health 
plans and health insurance issuers offering group or individual health 
insurance coverage to annually report to the Department of the 
Treasury, the Department of Labor (DOL), and the Department of Health 
and Human Services (HHS) (collectively, ``the Departments'') certain 
information about prescription drug and health care spending, premiums, 
and enrollment under the plan or coverage. This information will 
support the development of public reports that will be published by the 
Departments on prescription drug reimbursements for plans and coverage, 
prescription drug pricing trends, and the role of prescription drug 
costs in contributing to premium increases or decreases under the plans 
or coverage. The 2021 interim final rules, ``Prescription Drug and 
Health Care Spending'' (2021 interim final rules), issued by the 
Departments and the Office of Personnel Management (OPM) implement the 
provisions of section 9825 of the Code, section 725 of ERISA, and 
section 2799A-10 of the PHS Act, as enacted by section 204 of Title II 
of Division BB of the CAA. OPM joined the Departments in issuing the 
2021 interim final rules, requiring Federal Employees Health Benefits 
(FEHB) carriers to report information about prescription drug and 
health care spending, premiums, and plan enrollment in the same manner 
as a group health plan or health insurance issuer offering group or 
individual health insurance coverage. Form Number: CMS-10788 (OMB 
control number: 0938-1407); Frequency: Annually; Affected Public 
Sector: Private Sector (Business or other for-profits and Not-for-
profit institutions); Number of Respondents: 356; Total Annual 
Responses: 356; Total Annual Hours: 764,442. (For policy questions 
regarding this collection contact Christina Whitefield at 202-536-
8676.)

    Dated: March 21, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and 
Regulatory Affairs.
[FR Doc. 2023-06226 Filed 3-24-23; 8:45 am]
BILLING CODE 4120-01-P